Hospitals, docs asking patients with high-deductible plans to prepay

A 34-year-old is putting her needed hysterectomy on hold because her physician won’t perform the surgery unless she pays her $2,500 share of the cost upfront, and the hospital may demand the same before allowing the procedure.

“I’m so angry,” Tai Boxley said to Kaiser Health News. “If I need medical care I should be able to get it without having to afford it up front.”

Boxley’s situation isn’t unique. With ever higher deductibles and out-of-pocket limits in health plans, providers are more frequently asking for “point-of-service” payment. This may create a greater financial barrier to care, forcing patients to put off necessary procedures and putting hospitals in danger on violating Emergency Medical Treatment and Labor Act (EMTALA).

 “At the very least it’s poor form, and goes against the intent if not the actual wording of EMTALA,” said Vidor Friedman, MD, board member for the American College of Emergency Physicians.

For more on patients’ frustrations with the push for upfront payments, click on the link below: 

""
John Gregory, Senior Writer

John joined TriMed in 2016, focusing on healthcare policy and regulation. After graduating from Columbia College Chicago, he worked at FM News Chicago and Rivet News Radio, and worked on the state government and politics beat for the Illinois Radio Network. Outside of work, you may find him adding to his never-ending graphic novel collection.

Around the web

Cardiovascular devices are more likely to be in a Class I recall than any other device type. The FDA's approval process appears to be at least partially responsible, though the agency is working to make some serious changes. We spoke to a researcher who has been tracking these data for years to learn more. 

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country. 

Trimed Popup
Trimed Popup